The major averages fell on Tuesday to round out a tough month for the stock market. The Dow fell 0.71%. The S&P 500 shed 0.30%. The Nasdaq dipped 0.10%.
Monday after the bell. But it wasn't enough to get some on Wall Street off the sidelines.
"While the top-line story remains weak, things appear to have stopped getting worse," said UBS analyst Karl Keirstead in a note to clients Tuesday. "We remain Neutral-rated." "ZM continues to face the aftermath of the pandemic related pull forward of demand, particularly in the Online business," said analyst Fred Lee in a note to clients Tuesday. "But owing to the company's deep culture of innovation, ZM now has several potentially game-changing products in the market."
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
S&P 500, Dow trade lower in final hour Tuesday, putting stocks on pace for February lossesU.S. stocks were trading mostly lower Tuesday afternoon, with a focus on inflation that’s been hard to tame reigniting concerns on Wall Street about the...
Consulte Mais informação »
108 kg of cannabis shipped from Canada intercepted by Italian police200 packages of vacuum-sealed bud found in shipment said to contain absorbent animal mats — via TheGrowthOp
Consulte Mais informação »
Elon Musk Lays Off 200 More Twitter Staffers as Revenue Plunges: ReportTwitter fired at least 200 of its few remaining employees on Saturday night. The company’s workforce now sits below 2,000 employees.
Consulte Mais informação »
GBP/USD manages to defend and rebound from 200-day SMA amid a modest USD downtickGBP/USD manages to defend and rebound from 200-day SMA amid a modest USD downtick – by hareshmenghani GBPUSD RiskAppetite Fed Recession Currencies
Consulte Mais informação »
Shiba Inu Has 200 Trillion SHIB Sitting at Two Major Support Levels, Here's What It Means$SHIB on its way up after a bounce from the local support level, and on-chain data shows it will not drop below certain thresholds
Consulte Mais informação »
This Philadelphia company has over 200 patent applications for psychedelic medicationsThe Discovery Center in Philadelphia is seeking approval to bring 218 novel psychedelic drugs to consumers, each of which could potentially treat a range of mental health conditions.
Consulte Mais informação »